Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Buller

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 27, 2000
The glutathione S-transferase M1 genotype in ovarian cancerT A Lallas, S K McClain, M S Shahin, et al.
Cancer|November 7, 2000
The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinomaM S Shahin, J H Hughes, A K Sood, et al.
The Journal of Biological Chemistry|September 10, 1976
Progesterone-binding components of chick oviduct. In vitro effect of receptor subunits on gene transcriptionR E Buller, R J Schwartz, W T Schrader, et al.
Cancer Gene Therapy|July 1, 1997
The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosisR E Buller, A Sood, C Fullenkamp, et al.
Gynecologic Oncology|April 1, 1994
What is a normal CA125 level?T Alagoz, R E Buller, M Berman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancerS C Kim, W Ju, V Mahavni, et al.
Obstetrics and Gynecology|June 1, 1982
Massive ovarian mucinous cystadenoma of low malignant potentialR E Buller, H Holter, R K Laros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Distant metastases in ovarian cancer: association with p53 mutationsA K Sood, J I Sorosky, M Dolan, et al.
Journal of the National Cancer Institute|March 2, 1999
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancerR E Buller, A K Sood, T Lallas, et al.
Journal of Medical Genetics|July 28, 2001
The androgen receptor and DXS15-134 markers show a high rate of discordance for germline X chromosome inactivationV Mahavni, S C Kim, T A Benda, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 27, 2000
The glutathione S-transferase M1 genotype in ovarian cancerT A Lallas, S K McClain, M S Shahin, et al.
Cancer|November 7, 2000
The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinomaM S Shahin, J H Hughes, A K Sood, et al.
The Journal of Biological Chemistry|September 10, 1976
Progesterone-binding components of chick oviduct. In vitro effect of receptor subunits on gene transcriptionR E Buller, R J Schwartz, W T Schrader, et al.
Cancer Gene Therapy|July 1, 1997
The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosisR E Buller, A Sood, C Fullenkamp, et al.
Gynecologic Oncology|April 1, 1994
What is a normal CA125 level?T Alagoz, R E Buller, M Berman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancerS C Kim, W Ju, V Mahavni, et al.
Obstetrics and Gynecology|June 1, 1982
Massive ovarian mucinous cystadenoma of low malignant potentialR E Buller, H Holter, R K Laros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Distant metastases in ovarian cancer: association with p53 mutationsA K Sood, J I Sorosky, M Dolan, et al.
Journal of the National Cancer Institute|March 2, 1999
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancerR E Buller, A K Sood, T Lallas, et al.
Journal of Medical Genetics|July 28, 2001
The androgen receptor and DXS15-134 markers show a high rate of discordance for germline X chromosome inactivationV Mahavni, S C Kim, T A Benda, et al.
Pageof 10